Competition Mounts in Physician and Ambulatory EMR Segments

According to Kalorama Information’s Electronic Medical Records 2015, medium-sized physician practices represent the most frequently targeted client group of electronic medical record (EMR) vendors. Over 50 EMR vendors offer EMR solutions to practices of roughly 6 to 25 physicians, significantly more than the roughly 30 vendors for any given segment of the acute care market.


Carrier, Prenatal and Pediatric Genetic Testing Still a Big Draw for Investors and Labs

Genetic testing for inherited diseases has been a volatile industry space in recent years headlined by Myriad Genetics’ hold over BRCA testing and the subsequent opening of that market to competition with a 2013 Supreme Court ruling. Outside of testing for patient testing for oncology risk, a significant component of genetic testing is reproductive health-oriented testing for carrier genes and prenatal conditions.

Cartagenia Acquisition Demonstrates Need For Better LIS

Last year we suggested that a key driver of lab information systems was software upgrades due to genomic testing.   The kind of analysis being conducted  for clinical applications will require software that many players don’t have. Our report on( Laboratory Information Systems suggested key companies in diagnostics would have to make partnerships and acquisitions.    Now this is happening.

The New Workhorses in Proteomics Research – Q-TOFs and Orbitraps

Changes in the competitive and technological landscape of proteomics research can take a long time to take hold. Core instruments in translational research for biomarkers and drug targets, such as mass spectrometers (MS), may be replaced or upgraded in a laboratory only once every ten to fifteen years. Many proteomics core labs at universities and research centers still rely on manufacturer-discontinued MS systems, though reinforcements in the lab have been conspicuous in recent years.

CRM Devices Market Reaches 13 Billion

The global market for cardiac rhythm management devices such as pacemakers and defibrillators is worth about $13 billion for 2015, according to our recent report Cardiac Rhythm Device Markets (  The market has benefited from the demand to move to a more mobile, wireless and efficient system both within major health facilities and in the home treatment markets.


Subscribe to Kalorama Information Home RSS